Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 2
2004 1
2005 1
2008 1
2009 2
2012 1
2013 3
2014 2
2015 3
2016 5
2017 4
2018 4
2019 4
2020 8
2021 9
2022 3
2023 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

43 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy and safety of setmelanotide, an MC4R agonist, in individuals with severe obesity due to LEPR or POMC deficiency: single-arm, open-label, multicentre, phase 3 trials.
Clément K, van den Akker E, Argente J, Bahm A, Chung WK, Connors H, De Waele K, Farooqi IS, Gonneau-Lejeune J, Gordon G, Kohlsdorf K, Poitou C, Puder L, Swain J, Stewart M, Yuan G, Wabitsch M, Kühnen P; Setmelanotide POMC and LEPR Phase 3 Trial Investigators. Clément K, et al. Lancet Diabetes Endocrinol. 2020 Dec;8(12):960-970. doi: 10.1016/S2213-8587(20)30364-8. Epub 2020 Oct 30. Lancet Diabetes Endocrinol. 2020. PMID: 33137293 Clinical Trial.
Fertility preservation for female patients with childhood, adolescent, and young adult cancer: recommendations from the PanCareLIFE Consortium and the International Late Effects of Childhood Cancer Guideline Harmonization Group.
Mulder RL, Font-Gonzalez A, Hudson MM, van Santen HM, Loeffen EAH, Burns KC, Quinn GP, van Dulmen-den Broeder E, Byrne J, Haupt R, Wallace WH, van den Heuvel-Eibrink MM, Anazodo A, Anderson RA, Barnbrock A, Beck JD, Bos AME, Demeestere I, Denzer C, Di Iorgi N, Hoefgen HR, Kebudi R, Lambalk C, Langer T, Meacham LR, Rodriguez-Wallberg K, Stern C, Stutz-Grunder E, van Dorp W, Veening M, Veldkamp S, van der Meulen E, Constine LS, Kenney LB, van de Wetering MD, Kremer LCM, Levine J, Tissing WJE; PanCareLIFE Consortium. Mulder RL, et al. Among authors: denzer c. Lancet Oncol. 2021 Feb;22(2):e45-e56. doi: 10.1016/S1470-2045(20)30594-5. Lancet Oncol. 2021. PMID: 33539753 Review.
Lipodystrophy as a Late Effect after Stem Cell Transplantation.
Tews D, Schulz A, Denzer C, von Schnurbein J, Ceccarini G, Debatin KM, Wabitsch M. Tews D, et al. Among authors: denzer c. J Clin Med. 2021 Apr 8;10(8):1559. doi: 10.3390/jcm10081559. J Clin Med. 2021. PMID: 33917653 Free PMC article. Review.
Hypothalamic-Pituitary and Other Endocrine Surveillance Among Childhood Cancer Survivors.
van Iersel L, Mulder RL, Denzer C, Cohen LE, Spoudeas HA, Meacham LR, Sugden E, Schouten-van Meeteren AYN, Hoving EW, Packer RJ, Armstrong GT, Mostoufi-Moab S, Stades AM, van Vuurden D, Janssens GO, Thomas-Teinturier C, Murray RD, Di Iorgi N, Neggers SJCMM, Thompson J, Toogood AA, Gleeson H, Follin C, Bardi E, Torno L, Patterson B, Morsellino V, Sommer G, Clement SC, Srivastava D, Kiserud CE, Fernandez A, Scheinemann K, Raman S, Yuen KCJ, Wallace WH, Constine LS, Skinner R, Hudson MM, Kremer LCM, Chemaitilly W, van Santen HM. van Iersel L, et al. Among authors: denzer c. Endocr Rev. 2022 Sep 26;43(5):794-823. doi: 10.1210/endrev/bnab040. Endocr Rev. 2022. PMID: 34962573
Could setmelanotide be the game-changer for acquired hypothalamic obesity?
van Santen HM, Denzer C, Müller HL. van Santen HM, et al. Among authors: denzer c. Front Endocrinol (Lausanne). 2024 Jan 4;14:1307889. doi: 10.3389/fendo.2023.1307889. eCollection 2023. Front Endocrinol (Lausanne). 2024. PMID: 38239988 Free PMC article. Clinical Trial.
Communication and ethical considerations for fertility preservation for patients with childhood, adolescent, and young adult cancer: recommendations from the PanCareLIFE Consortium and the International Late Effects of Childhood Cancer Guideline Harmonization Group.
Mulder RL, Font-Gonzalez A, van Dulmen-den Broeder E, Quinn GP, Ginsberg JP, Loeffen EAH, Hudson MM, Burns KC, van Santen HM, Berger C, Diesch T, Dirksen U, Giwercman A, Gracia C, Hunter SE, Kelvin JF, Klosky JL, Laven JSE, Lockart BA, Neggers SJCMM, Peate M, Phillips B, Reed DR, Tinner EME, Byrne J, Veening M, van de Berg M, Verhaak CM, Anazodo A, Rodriguez-Wallberg K, van den Heuvel-Eibrink MM, Asogwa OA, Brownsdon A, Wallace WH, Green DM, Skinner R, Haupt R, Kenney LB, Levine J, van de Wetering MD, Tissing WJE, Paul NW, Kremer LCM, Inthorn J; PanCareLIFE Consortium. Mulder RL, et al. Lancet Oncol. 2021 Feb;22(2):e68-e80. doi: 10.1016/S1470-2045(20)30595-7. Lancet Oncol. 2021. PMID: 33539755 Review.
Sleep and glycemic control in adolescents with type 1 diabetes.
von Schnurbein J, Boettcher C, Brandt S, Karges B, Dunstheimer D, Galler A, Denzer C, Denzer F, Vollbach H, Wabitsch M, Roenneberg T, Vetter C. von Schnurbein J, et al. Among authors: denzer c. Pediatr Diabetes. 2018 Feb;19(1):143-149. doi: 10.1111/pedi.12538. Epub 2017 Jun 14. Pediatr Diabetes. 2018. PMID: 28880049
43 results